A Study Assessing Arrhythmia Mapping With a Multi-Electrode Mapping Catheter
NCT: NCT07116525 · RECRUITING
NCT IDNCT07116525
StatusRECRUITING
Start Date2025-09-15
Completion2027-02-07
SponsorBiosense Webster, Inc. (INDUSTRY)
First posted
Last updated
Brief Summary
The purpose of this study is to assess the safety and feasibility of the investigational catheter for mapping the atrial and ventricular regions of the heart.
Frequently Asked Questions
What is A Study Assessing Arrhythmia Mapping With a Multi-Electrode Mapping Catheter?
A Study Assessing Arrhythmia Mapping With a Multi-Electrode Mapping Catheter is a clinical trial registered under NCT07116525. Current status: RECRUITING.
What is the status of NCT07116525?
The current status of NCT07116525 (A Study Assessing Arrhythmia Mapping With a Multi-Electrode Mapping Catheter) is: RECRUITING.
When did A Study Assessing Arrhythmia Mapping With a Multi-Electrode Mapping Catheter start?
A Study Assessing Arrhythmia Mapping With a Multi-Electrode Mapping Catheter started on 2025-09-15.
Related Devices
K201750Pentaray Nav eco High-Density Mapping CatheterBiosense Webster, Inc.
K231312PENTARAY® NAV ECO High Density Mapping Catheter, DECANAV® Mapping Catheter, Webster® CS Catheter with Auto ID, Webster® CS Catheter with EZ Steer Technology, Webster® CS Catheter with EZ Steer Technology with Auto IDBiosense Webster, Inc.
K193237Carto Octaray Mapping Catheter with Trueref TechnologyBiosense Webster, Inc.
K193632LassoStar Circular Mapping CatheterBiosense Webster, Inc.
K211219LASSOSTAR NAV Circular Mapping CatheterBiosense Webster, Inc.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.